Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

Michael H Olsen; Kristian Wachtell; Hans Ibsen; Lars Lindholm; Sverre E Kjeldsen; Per Omvik; Markku S Nieminen; Björn Dahlöf; Peter M Okin; Richard B Devereux

doi:10.1097/HJH.0b013e328344daa3

Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

Michael H Olsen
, Kristian Wachtell
, Hans Ibsen
, Lars Lindholm
, Sverre E Kjeldsen
, Per Omvik
, Markku S Nieminen
, Björn Dahlöf
, Peter M Okin
, Richard B Devereux

Medicinsk Afdeling, Glostrup AHH

5 Citationer (Scopus)

Abstract

To investigate whether in-treatment measurements of subclinical organ damage (SOD) assessed by elevated urine albumin/creatinine ratio (UACR) or electrocardiographic left ventricular hypertrophy improved the prediction of the composite cardiovascular endpoint of cardiovascular death, nonfatal myocardial infarction and stroke beyond in-treatment Framingham risk score (FRS).

Originalsprog	Engelsk
Tidsskrift	Journal of Hypertension
Vol/bind	29
Udgave nummer	5
Sider (fra-til)	997-1004
Antal sider	8
DOI	https://doi.org/10.1097/HJH.0b013e328344daa3
Status	Udgivet - 1 maj 2011

Adgang til dokumentet

10.1097/HJH.0b013e328344daa3

Citationsformater

Olsen, M. H., Wachtell, K., Ibsen, H., Lindholm, L., Kjeldsen, S. E., Omvik, P., Nieminen, M. S., Dahlöf, B., Okin, P. M., & Devereux, R. B. (2011). Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy. Journal of Hypertension, 29(5), 997-1004. https://doi.org/10.1097/HJH.0b013e328344daa3

Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy. / Olsen, Michael H; Wachtell, Kristian; Ibsen, Hans et al.
I: Journal of Hypertension, Bind 29, Nr. 5, 01.05.2011, s. 997-1004.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Olsen, MH, Wachtell, K, Ibsen, H, Lindholm, L, Kjeldsen, SE, Omvik, P, Nieminen, MS, Dahlöf, B, Okin, PM & Devereux, RB 2011, 'Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy', Journal of Hypertension, bind 29, nr. 5, s. 997-1004. https://doi.org/10.1097/HJH.0b013e328344daa3

@article{7e0434732e974b6d94ab9f34e5d0a3db,

title = "Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy",

abstract = "To investigate whether in-treatment measurements of subclinical organ damage (SOD) assessed by elevated urine albumin/creatinine ratio (UACR) or electrocardiographic left ventricular hypertrophy improved the prediction of the composite cardiovascular endpoint of cardiovascular death, nonfatal myocardial infarction and stroke beyond in-treatment Framingham risk score (FRS).",

author = "Olsen, \{Michael H\} and Kristian Wachtell and Hans Ibsen and Lars Lindholm and Kjeldsen, \{Sverre E\} and Per Omvik and Nieminen, \{Markku S\} and Bj{\"o}rn Dahl{\"o}f and Okin, \{Peter M\} and Devereux, \{Richard B\}",

note = "{\textcopyright} 2011 Wolters Kluwer Health | Lippincott Williams \& Wilkins",

year = "2011",

month = may,

day = "1",

doi = "10.1097/HJH.0b013e328344daa3",

language = "English",

volume = "29",

pages = "997--1004",

journal = "Journal of Hypertension",

issn = "1473-5598",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

AU - Olsen, Michael H

AU - Wachtell, Kristian

AU - Ibsen, Hans

AU - Lindholm, Lars

AU - Kjeldsen, Sverre E

AU - Omvik, Per

AU - Nieminen, Markku S

AU - Dahlöf, Björn

AU - Okin, Peter M

AU - Devereux, Richard B

PY - 2011/5/1

Y1 - 2011/5/1

N2 - To investigate whether in-treatment measurements of subclinical organ damage (SOD) assessed by elevated urine albumin/creatinine ratio (UACR) or electrocardiographic left ventricular hypertrophy improved the prediction of the composite cardiovascular endpoint of cardiovascular death, nonfatal myocardial infarction and stroke beyond in-treatment Framingham risk score (FRS).

AB - To investigate whether in-treatment measurements of subclinical organ damage (SOD) assessed by elevated urine albumin/creatinine ratio (UACR) or electrocardiographic left ventricular hypertrophy improved the prediction of the composite cardiovascular endpoint of cardiovascular death, nonfatal myocardial infarction and stroke beyond in-treatment Framingham risk score (FRS).

U2 - 10.1097/HJH.0b013e328344daa3

DO - 10.1097/HJH.0b013e328344daa3

M3 - Journal article

C2 - 21358415

SN - 1473-5598

VL - 29

SP - 997

EP - 1004

JO - Journal of Hypertension

JF - Journal of Hypertension

IS - 5

ER -

Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater